Butyrylcholinesterase for protection from organophosphorus poisons

Catalytic complexities and hysteretic behavior

Patrick Masson, Oksana Lockridge

Research output: Contribution to journalReview article

131 Citations (Scopus)

Abstract

Butyrylcholinesterase is a promiscuous enzyme that displays complex kinetic behavior. It is toxicologically important because it detoxifies organophosphorus poisons (OP) by making a covalent bond with the OP. The OP and the butyrylcholinesterase are both inactivated in the process. Inactivation of butyrylcholinesterase has no adverse effects. However, inactivation of acetylcholinesterase in nerve synapses can be lethal. OP-inhibited butyrylcholinesterase and acetylcholinesterase can be reactivated with oximes provided the OP has not aged. Strategies for preventing the toxicity of OP include (a) treatment with an OP scavenger, (b) reaction of non-aged enzyme with oximes, (c) reactivation of aged enzyme, (d) slowing down aging with peripheral site ligands, and (e) design of mutants that rapidly hydrolyze OP. Option (a) has progressed through phase I clinical trials with human butyrylcholinesterase. Option (b) is in routine clinical use. The others are at the basic research level. Butyrylcholinesterase displays complex kinetic behavior including activation by positively charged esters, ability to hydrolyze amides, and a lag time (hysteresis) preceding hydrolysis of benzoylcholine and N-methylindoxyl acetate. Mass spectrometry has identified new OP binding motifs on tyrosine and lysine in proteins that have no active site serine. It is proposed, but not yet proven, that low dose exposure involves OP modification of proteins that have no active site serine.

Original languageEnglish (US)
Pages (from-to)107-120
Number of pages14
JournalArchives of Biochemistry and Biophysics
Volume494
Issue number2
DOIs
StatePublished - Feb 1 2010

Fingerprint

Butyrylcholinesterase
Poisons
Oximes
Acetylcholinesterase
Serine
Benzoylcholine
Catalytic Domain
Enzymes
Clinical Trials, Phase I
Kinetics
Aptitude
Covalent bonds
Amides
Synapses
Lysine
Mass spectrometry
Toxicity
Tyrosine
Hysteresis
Hydrolysis

Keywords

  • Aryl acylamidase
  • Bioscavenger
  • Dehydroalanine
  • Hysteresis
  • Mass spectrometry
  • Phosphylation

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Butyrylcholinesterase for protection from organophosphorus poisons : Catalytic complexities and hysteretic behavior. / Masson, Patrick; Lockridge, Oksana.

In: Archives of Biochemistry and Biophysics, Vol. 494, No. 2, 01.02.2010, p. 107-120.

Research output: Contribution to journalReview article

@article{d5547d8aa414499799835626ff6d42ed,
title = "Butyrylcholinesterase for protection from organophosphorus poisons: Catalytic complexities and hysteretic behavior",
abstract = "Butyrylcholinesterase is a promiscuous enzyme that displays complex kinetic behavior. It is toxicologically important because it detoxifies organophosphorus poisons (OP) by making a covalent bond with the OP. The OP and the butyrylcholinesterase are both inactivated in the process. Inactivation of butyrylcholinesterase has no adverse effects. However, inactivation of acetylcholinesterase in nerve synapses can be lethal. OP-inhibited butyrylcholinesterase and acetylcholinesterase can be reactivated with oximes provided the OP has not aged. Strategies for preventing the toxicity of OP include (a) treatment with an OP scavenger, (b) reaction of non-aged enzyme with oximes, (c) reactivation of aged enzyme, (d) slowing down aging with peripheral site ligands, and (e) design of mutants that rapidly hydrolyze OP. Option (a) has progressed through phase I clinical trials with human butyrylcholinesterase. Option (b) is in routine clinical use. The others are at the basic research level. Butyrylcholinesterase displays complex kinetic behavior including activation by positively charged esters, ability to hydrolyze amides, and a lag time (hysteresis) preceding hydrolysis of benzoylcholine and N-methylindoxyl acetate. Mass spectrometry has identified new OP binding motifs on tyrosine and lysine in proteins that have no active site serine. It is proposed, but not yet proven, that low dose exposure involves OP modification of proteins that have no active site serine.",
keywords = "Aryl acylamidase, Bioscavenger, Dehydroalanine, Hysteresis, Mass spectrometry, Phosphylation",
author = "Patrick Masson and Oksana Lockridge",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.abb.2009.12.005",
language = "English (US)",
volume = "494",
pages = "107--120",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Butyrylcholinesterase for protection from organophosphorus poisons

T2 - Catalytic complexities and hysteretic behavior

AU - Masson, Patrick

AU - Lockridge, Oksana

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Butyrylcholinesterase is a promiscuous enzyme that displays complex kinetic behavior. It is toxicologically important because it detoxifies organophosphorus poisons (OP) by making a covalent bond with the OP. The OP and the butyrylcholinesterase are both inactivated in the process. Inactivation of butyrylcholinesterase has no adverse effects. However, inactivation of acetylcholinesterase in nerve synapses can be lethal. OP-inhibited butyrylcholinesterase and acetylcholinesterase can be reactivated with oximes provided the OP has not aged. Strategies for preventing the toxicity of OP include (a) treatment with an OP scavenger, (b) reaction of non-aged enzyme with oximes, (c) reactivation of aged enzyme, (d) slowing down aging with peripheral site ligands, and (e) design of mutants that rapidly hydrolyze OP. Option (a) has progressed through phase I clinical trials with human butyrylcholinesterase. Option (b) is in routine clinical use. The others are at the basic research level. Butyrylcholinesterase displays complex kinetic behavior including activation by positively charged esters, ability to hydrolyze amides, and a lag time (hysteresis) preceding hydrolysis of benzoylcholine and N-methylindoxyl acetate. Mass spectrometry has identified new OP binding motifs on tyrosine and lysine in proteins that have no active site serine. It is proposed, but not yet proven, that low dose exposure involves OP modification of proteins that have no active site serine.

AB - Butyrylcholinesterase is a promiscuous enzyme that displays complex kinetic behavior. It is toxicologically important because it detoxifies organophosphorus poisons (OP) by making a covalent bond with the OP. The OP and the butyrylcholinesterase are both inactivated in the process. Inactivation of butyrylcholinesterase has no adverse effects. However, inactivation of acetylcholinesterase in nerve synapses can be lethal. OP-inhibited butyrylcholinesterase and acetylcholinesterase can be reactivated with oximes provided the OP has not aged. Strategies for preventing the toxicity of OP include (a) treatment with an OP scavenger, (b) reaction of non-aged enzyme with oximes, (c) reactivation of aged enzyme, (d) slowing down aging with peripheral site ligands, and (e) design of mutants that rapidly hydrolyze OP. Option (a) has progressed through phase I clinical trials with human butyrylcholinesterase. Option (b) is in routine clinical use. The others are at the basic research level. Butyrylcholinesterase displays complex kinetic behavior including activation by positively charged esters, ability to hydrolyze amides, and a lag time (hysteresis) preceding hydrolysis of benzoylcholine and N-methylindoxyl acetate. Mass spectrometry has identified new OP binding motifs on tyrosine and lysine in proteins that have no active site serine. It is proposed, but not yet proven, that low dose exposure involves OP modification of proteins that have no active site serine.

KW - Aryl acylamidase

KW - Bioscavenger

KW - Dehydroalanine

KW - Hysteresis

KW - Mass spectrometry

KW - Phosphylation

UR - http://www.scopus.com/inward/record.url?scp=75549088598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75549088598&partnerID=8YFLogxK

U2 - 10.1016/j.abb.2009.12.005

DO - 10.1016/j.abb.2009.12.005

M3 - Review article

VL - 494

SP - 107

EP - 120

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -